The biopharmaceutical and healthcare industries, long seen as cornerstones of innovation, are currently grappling with a...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
The biotech industry, renowned for its rapid advancements and groundbreaking research, faced a significant wave of layof...
Over the past six months, the leading MedTech companies have made remarkable progress in product innovation, strategic p...
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...
The 3rd World ADC Asia Conference, held from June 25th to 27th, 2024, in Incheon, South Korea, was a landmark event in t...
The Life Sciences Industry: Pitfalls and the Impact of Failed Clinical Trials in 2024 The life sciences industry is at ...
The following report provides detailed analysis of Mergers and Acquisitions of BioPharma and Pharmaceuticals companies u...
A Shifting Landscape: The Bio Industry's May 2024 Layoffs May 2024 witnessed a wave of layoffs across the bio industry,...
March 2024 has been marked by a series of layoffs in the biotech and pharmaceutical sector, raising concerns and drawing...
In February, the Biotech and BioPharma industries faced a wave of strategic layoffs, signaling a significant shift towar...
Growth and innovation in the global life sciences industry has analysts predicting the market size will increase by clos...
IESE Business School releases today a new report on corporate venturing in deep tech in East and Southeast Asia, which f...
Pharma 4.0 concepts are taking hold in pharmaceutical manufacturing. The industry's unique characteristics are driving i...
Hong Kong's The South China Morning Post announced the launch of China Digital Health Report 20...
The hepatitis C virus (HCV) therapeutics market in Japan is highly competitive with stiff competition between Gilead and...
Rapid expansion of digital healthcare for the provision of delivery, medical support, and intervention through mobile te...
Hong Kong-based Sihuan Pharmaceutical Holdings Group Ltd. announced that on 26 August 2020, the Company granted a t...
The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...
As analytics continues to guide and drive the world’s response to COVID-19, SAS debuts the final instalment of its...
Following the announcement that Renalytix AI’s KidneyIntelX™ platform will be used to assess the risk o...
Ventilator shortages are a critical reality as the COVID-19 outbreak continues to worsen globally. According to GlobalDa...
There is currently 445 chimeric antigen receptor (CAR-T cell) therapies under development by companies headquartered acr...
The Duterte administration is implementing a three-pronged strategy to mitigate the social and economic impact of t...
The pneumococcal vaccines market is expected to grow from $5.11bn in 2018 to $6.24bn in 2028 across ...
The impact of the COVID-19 pandemic on the global economy has business leaders in an unprecedented state of uncertainty....
The axial spondyloarthritis (axSpA) market across the five growth markets (5GM*) in the Asia-Pacific (APAC) region will ...
In an era where the healthcare industry is moving toward personalized care solutions and the acknowledgment of inherent ...
Digital marketing in pharma is gaining increasing importance in recent times and Indian multinational pharmaceutical com...
ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the fore...
Following the recent official gazette notification from the Ministry of Health & Family Welfare (MOHFW) of India tha...
Expectations for biosimilars are high in 2020, and the drug class will finally begin to make its mark in the US, says Gl...
Malaysia’s aspiration to push HealthTech to the forefront will provide myriad opportunities to innovative domestic...
Readers of GlobalData’s Pharmaceutical Technology have been voting for whether Britain’s exit from the EU an...
Galen Growth, the leading HealthTech intelligence, analytics and advisory firm serving Fortune 500 companies and global ...
The spinal muscular atrophy (SMA) market across the five growth markets ((5GM) Australia, China, India, Japan and South ...
Asia has driven a boom in recent years in terms of R&D spending, venture capital funding, academic publications, and...
Increasing patient scans for oncology, paediatrics, soft tissue imaging, and the ability to combine tests, which cannot ...
The global SDS polyacrylamide gel electrophoresis (PAGE) market is set to exhibit a promising 5% CAGR during the forecas...
The respiratory syncytial virus (RSV) market is expected to grow at a compound annual growth rate (CAGR) of 44.7% from U...
Secure messaging in healthcare is set to become a billion-dollar market by 2029, as indicated by a new research study. W...
Persistence Market Research (PMR), an innovative and specialized supplier of market intelligence reports and&n...
Luye Pharma Group released its financial results for the first half of 2019 on 28 August 2019. The results sho...
The global Neurorehabilitation Devices Market is foreseen to project a notable growth because of the rising pr...
The "Asia Pacific Cardiovascular Devices Market to 2027 - Regional Analysis and Forecasts By Device, Pacemaker, Ste...
The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8....
Orphan drugs market analysis considers sales from both biologics and non-biologics. The analysis also considers the sale...
The global single-use filtration assemblies market size is expected to reach USD 7.0 billion by 2026 and is pr...
As per the report, the global molecular imaging market analysis conducted by BIS Research, the market was valued at appr...
South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...
Galen Growth Asia, the leading exclusive HealthTech research, analytics and advisory firm in Asia Pac (Asia) serving For...
The total spinal muscular atrophy (SMA) market was estimated to be worth US$1.5bn across the seven major markets (7MM: U...
Increasing usage of therapeutically more effective drugs for the treatment of chronic diseases is expected to drive the ...
The Chinese State Medical Insurance Administration introduced a new procurement in a recent round of reforms pilot schem...
In Abu Dhabi, The International Diabetes Federation (IDF) presented the interim results of the first ever multi-country ...
85% Singaporeans have suffered from head and body pain, with nearly half (42%) suffering weekly from body pain 1 in 2...
Cell banking market is expected to grow at an exponential rate in the coming years owing to the growing demand for biolo...
Ranbaxy became the first Indian firm to develop a new drug called Synriam for malaria, which is a health menace that c...
India, which has the second largest population in the world and is among the top three nations in terms of patient pool,...
Singapore, a cosmopolitan city state that offers world-class living standards and attracts talent from all over the glob...
US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...
One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum A...
Singapore: Asia has earned the status of a fast growing market for clinical research due to its diverse population, fast...
Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a gro...
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...
Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutica...
Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing ...
Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chin...
With rapid growth of life sciences industry in Asia, we have seen many success stories over the last decade. However, an...
To enhance its market opportunities and drive business growth, China Resources Sanjiu Medical & Pharmaceutical is ...
The global life science industry has been facing a financial crunch and The United Laboratories too has felt the jolt....
Singapore: The healthcare industry is at a disruptive stage globally and patient's involvement and engagement in their o...
North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...
Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...
A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...
Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...
Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...
The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...
Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...
Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical product...
In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest sh...
China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in...
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...
China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...
Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...
Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...
Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top thr...
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar ...
